Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC25A2 mRNA | CTD | PMID:22079256 | (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of SLC25A2 mRNA | CTD | PMID:22079256 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC25A2 mRNA | CTD | PMID:33387578 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of SLC25A2 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SLC25A2 exon and Benzo(a)pyrene affects the methylation of SLC25A2 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC25A2 mRNA | CTD | PMID:25181051 and PMID:34947998 | copper atom | increases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of SLC25A2 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of SLC25A2 mRNA | CTD | PMID:26033743 | ethanol | increases expression | ISO | Slc25a2 (Mus musculus) | 6480464 | Ethanol results in increased expression of SLC25A2 mRNA | CTD | PMID:30319688 | furan | decreases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | furan results in decreased expression of SLC25A2 mRNA | CTD | PMID:25539665 | gentamycin | decreases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SLC25A2 mRNA | CTD | PMID:33387578 | hydroquinone O-beta-D-glucopyranoside | decreases expression | EXP | | 6480464 | Arbutin results in decreased expression of SLC25A2 mRNA | CTD | PMID:17103032 | kojic acid | decreases expression | EXP | | 6480464 | kojic acid results in decreased expression of SLC25A2 mRNA | CTD | PMID:16595896 | lamivudine | multiple interactions | ISO | Slc25a2 (Mus musculus) | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A2 mRNA | CTD | PMID:18313992 | levonorgestrel | multiple interactions | EXP | | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC25A2 mRNA | CTD | PMID:19074003 | paracetamol | multiple interactions | ISO | Slc25a2 (Mus musculus) | 6480464 | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SLC25A2 mRNA] | CTD | PMID:18700144 | paracetamol | decreases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of SLC25A2 mRNA | CTD | PMID:33387578 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC25A2 mRNA | CTD | PMID:19710929 | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of SLC25A2 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC25A2 mRNA | CTD | PMID:22079256 | testosterone undecanoate | multiple interactions | EXP | | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC25A2 mRNA | CTD | PMID:19074003 | thioacetamide | increases methylation | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased methylation of SLC25A2 promoter | CTD | PMID:27914986 | titanium dioxide | decreases expression | ISO | Slc25a2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SLC25A2 mRNA | CTD | PMID:29264374 | trichloroethene | decreases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of SLC25A2 mRNA | CTD | PMID:33387578 | vinclozolin | increases expression | ISO | Slc25a2 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of SLC25A2 mRNA | CTD | PMID:23034163 | zidovudine | multiple interactions | ISO | Slc25a2 (Mus musculus) | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A2 mRNA | CTD | PMID:18313992 | |